Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2014, Article ID 926836, 9 pages
http://dx.doi.org/10.1155/2014/926836
Review Article

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis

1Division of Rheumatology, Misericordia e Dolce Hospital, Via Cavour 87/89, 59100 Prato, Italy
2Section of Hygiene, Institute of Public Health, Department of Public Health, Università Cattolica del Sacro Cuore, L.go F.Vito 1, 00168 Rome, Italy
3Translational Research Unit, Department of Epidemiology and Preclinical Research, INMI, Via Portuense 292, 00149 Rome, Italy
4Rheumatology Unit, Interdisciplinary Department of Medicine, University of Bari, Piazza Giulio Cesare 1, 70124 Bari, Italy
5Dermatology Clinic/ASF Department of Surgery and Translational Medicine, University of Florence, Via Lorenzo Il Magnifico 104, 50129 Florence, Italy
6Section of Infectious Diseases, Department of Internal Medicine, Second University of Naples, Via S. Pansini 5, 80131 Naples, Italy

Received 25 March 2014; Revised 26 May 2014; Accepted 11 June 2014; Published 7 July 2014

Academic Editor: Luis R. Espinoza

Copyright © 2014 Fabrizio Cantini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [36 citations]

The following is the list of published articles that have cited the current article.

  • Shunsuke Mori, and Shigetoshi Fujiyama, “Hepatitis B virus reactivation associated with antirheumatic therapy: risk and prophylaxis recommendations,” World Journal Of Gastroenterology, vol. 21, no. 36, pp. 10274–10289, 2015. View at Publisher · View at Google Scholar
  • Paula Sousa, and Matthieu Allez, “Complications of biologics in inflammatory bowel disease,” Current Opinion In Gastroenterology, vol. 31, no. 4, pp. 296–302, 2015. View at Publisher · View at Google Scholar
  • Thomas Mina, Samad Amini Bavil Olyaee, Frank Tacke, Piet Maes, Marc Van Ranst, and Mahmoud Reza Pourkarim, “Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development,” Hepatitis Monthly, vol. 15, no. 6, 2015. View at Publisher · View at Google Scholar
  • Worawit Louthrenoo, “Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases,” Best Practice & Research Clinical Rheumatology, 2015. View at Publisher · View at Google Scholar
  • Mayra Lindo Ricce, Verónica Martín Domínguez, Yolanda Real, Leticia González Moreno, Constanza Martínez Mera, Maximiliano Aragües Montañes, Carlos Humberto Gordillo Vélez, and Javier P. Gisbert, “Colitis ulcerosa asociada a pancreatitis autoinmune, sialoadenitis y vasculitis leucocitoclástica,” Gastroenterología y Hepatología, 2015. View at Publisher · View at Google Scholar
  • Fabiola Atzeni, Luigi Gianturco, Rossella Talotta, Valentina Varisco, Maria Chiara Ditto, Maurizio Turiel, and Piercarlo Sarzi-Puttini, “Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern?,” Immunotherapy, vol. 7, no. 4, pp. 353–361, 2015. View at Publisher · View at Google Scholar
  • Viviana Lora, Lorenzo Nosotti, Claudio Bonifati, and Dario Graceffa, “Management of psoriasis patients with hepatitis B or hepatitis C virus infection,” World Journal of Gastroenterology, vol. 22, no. 28, pp. 6444–6455, 2016. View at Publisher · View at Google Scholar
  • Vincent Mallet, Florian van Bömmel, Christopher Doerig, Sven Pischke, Olivier Hermine, Anna Locasciulli, Catherine Cordonnier, Thomas Berg, Darius Moradpour, Heiner Wedemeyer, and Per Ljungman, “Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5),” The Lancet Infectious Diseases, vol. 16, no. 5, pp. 606–617, 2016. View at Publisher · View at Google Scholar
  • Mauro Viganò, Giuseppe Serra, Giovanni Casella, Glenda Grossi, and Pietro Lampertico, “Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders,” Expert Opinion on Biological Therapy, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Melissa Padovan, Matteo Filippini, Angela Tincani, Elisabetta Lanciano, Eleonora Bruschi, Oscar Epis, Pietro Garau, Alessandro Mathieu, Eleonora Celletti, Leopoldo Giani, Paola Tomietto, Fabiola Atzeni, Piercarlo Sarzi Puttini, Francesca Zuliani, Salvatore De Vita, Francesco Trotta, Anastasio Grilli, Massimo Puoti, and Marcello Govoni, “Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection,” Arthritis Care & Research, vol. 68, no. 6, pp. 738–743, 2016. View at Publisher · View at Google Scholar
  • Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassara, Olga Kaloudi, Ennio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, Maurizio Benucci, Francesca Li Gobbi, Valentina Grossi, Maria Infantino, Francesca Meacci, Mariangela Manfredi, Serena Guiducci, Silvia Bellando-Randone, Marco Matucci-Cerinic, Rosario Foti, Marcella Di Gangi, Marta Mosca, Chiara Tani, Fabrizio Palmieri, and Delia Goletti, “Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis,” Seminars In Arthritis And Rheumatism, vol. 45, no. 5, pp. 519–532, 2016. View at Publisher · View at Google Scholar
  • John R. North, Shunsuke Takenaka, Annett Rozek, Agnieszka Kielczewska, Steven Opal, Lisa A. Morici, B.Brett Finlay, Christopher J. Schaber, Richard Straube, and Oreola Donini, “A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy,” Journal of Biotechnology, 2016. View at Publisher · View at Google Scholar
  • Mayra Lindo Ricce, Verónica Martín Domínguez, Yolanda Real, Leticia González Moreno, Constanza Martínez Mera, Maximiliano Aragües Montañes, Carlos Humberto Gordillo Vélez, and Javier P. Gisbert, “Ulcerative colitis associated with autoimmune pancreatitis, sialadenitis and leukocytoclastic vasculitis,” Gastroenterología y Hepatología (English Edition), 2016. View at Publisher · View at Google Scholar
  • Christos Koutsianas, Konstantinos Thomas, and Dimitrios Vassilopoulos, “Prevention of HBV reactivation in patients treated with biologic agents,” Expert Review of Clinical Pharmacology, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Marco Krasselt, Jean-Philipp Ivanov, Christoph Baerwald, and Olga Seifert, “Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic,” Rheumatology International, 2016. View at Publisher · View at Google Scholar
  • Giovanni Raimondo, and Teresa Pollicino, “Occult HBV Infection,” Hepatitis B Virus in Human Diseases, pp. 277–301, 2016. View at Publisher · View at Google Scholar
  • Marco Sebastiani, Fabiola Atzeni, Laura Milazzo, Luca Quartuccio, Carlo Scirè, Giovanni Battista Gaeta, Giovanni Lapadula, Orlando Armignacco, Marcello Tavio, Ignazio Olivieri, Pierluigi Meroni, Laura Bazzichi, Walter Grassi, Alessandro Mathieu, Claudio Mastroianni, Evangelista Sagnelli, Teresa Santantonio, Caterina Uberti Foppa, Massimo Puoti, Loredana Sarmati, Paolo Airò, Oscar Massimiliano Epis, Rossana Scrivo, Miriam Gargiulo, Agostino Riva, Andreina Manfredi, Giovanni Ciancio, Gianguglielmo Zehender, Gloria Taliani, Luca Meroni, Salvatore Sollima, Piercarlo Sarzi-Puttini, and Massimo Galli, “Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne,” Revue du Rhumatisme, 2017. View at Publisher · View at Google Scholar
  • Fabiola Atzeni, Ignazio Francesco Masala, Manuela Di Franco, and Piercarlo Sarzi-Puttini, “Infections in rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 29, no. 4, pp. 323–330, 2017. View at Publisher · View at Google Scholar
  • Marco Sebastiani, Fabiola Atzeni, Laura Milazzo, Luca Quartuccio, Carlo Scirè, Giovanni Battista Gaeta, Giovanni Lapadula, Orlando Armignacco, Marcello Tavio, Ignazio Olivieri, Pierluigi Meroni, Laura Bazzichi, Walter Grassi, Alessandro Mathieu, Claudio Mastroianni, Evangelista Sagnelli, Teresa Santantonio, Caterina Uberti Foppa, Massimo Puoti, Loredana Sarmati, Paolo Airò, Oscar Massimiliano Epis, Rossana Scrivo, Miriam Gargiulo, Agostino Riva, Andreina Manfredi, Giovanni Ciancio, Gianguglielmo Zehender, Gloria Taliani, Luca Meroni, Salvatore Sollima, Piercarlo Sarzi-Puttini, and Massimo Galli, “Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis,” Joint Bone Spine, 2017. View at Publisher · View at Google Scholar
  • Tzu-Chieh Lin, Nikroo Hashemi, Seoyoung C. Kim, Yea-Huei Kao Yang, Kazuki Yoshida, Sara Tedeschi, Rishi Desai, and Daniel H. Solomon, “Practice Pattern of Hepatitis B Testing in Rheumatoid Arthritis Patients: A Cross-National Comparison Between the US and Taiwan,” Arthritis Care & Research, 2017. View at Publisher · View at Google Scholar
  • R. Pereira, I. Raposo, F. Nery, and T. Torres, “Risk of hepatitis B virus reactivation in patients treated with anti-TNFα agents for immune-mediated inflammatory diseases,” Actas Dermo-Sifiliográficas, 2017. View at Publisher · View at Google Scholar
  • J. Braun, and J. Kay, “The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis,” Expert Opinion on Drug Safety, pp. 1–14, 2017. View at Publisher · View at Google Scholar
  • Mark Lebwohl, and Margot Chima, “TNF inhibitors for psoriasis,” Seminars in Cutaneous Medicine and Surgery, vol. 37, no. 3, pp. 134–142, 2018. View at Publisher · View at Google Scholar
  • Mariantonietta Pisaturo, Giovanni Di Caprio, Federica Calò, Federica Portunato, Salvatore Martini, and Nicola Coppola, “Management of HBV reactivation in non-oncological patients,” Expert Review of Anti-infective Therapy, vol. 16, no. 8, pp. 611–624, 2018. View at Publisher · View at Google Scholar
  • Christopher R Holroyd, Rakhi Seth, Marwan Bukhari, Anshuman Malaviya, Claire Holmes, Elizabeth Curtis, Christopher Chan, Mohammed A Yusuf, Anna Litwic, Susan Smolen, Joanne Topliffe, Sarah Bennett, Jennifer Humphreys, Muriel Green, and Jo Ledingham, “The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis,” Rheumatology, 2018. View at Publisher · View at Google Scholar
  • Anil Arora, Anil Chandra Anand, Ashish Kumar, Shivaram Prasad Singh, Rakesh Aggarwal, Radha Krishan Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod Kumar Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, N Murugan, Aabha Nagral, Amarender S Puri, Padaki Nagaraja Rao, Neeraj Saraf, Vivek Anand Saraswat, Sanjeev Sehgal, Praveen Sharma, Koticherry Thrivikrama Shenoy, and Manav Wadhawan, “INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Steroids,” Journal of Clinical and Experimental Hepatology, 2018. View at Publisher · View at Google Scholar
  • R. Pereira, I. Raposo, F. Nery, and T. Torres, “Risk of hepatitis B virus reactivation in patients treated with anti-TNFα agents for immune-mediated inflammatory diseases,” Actas Dermo-Sifiliográficas (English Edition), vol. 109, no. 3, pp. 285–287, 2018. View at Publisher · View at Google Scholar
  • Mary Patricia Pauly, Lue-Yen Tucker, Jean-Luc Szpakowski, Joanna B. Ready, David Baer, Jessica Hwang, and Anna S.-F. Lok, “Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists,” Clinical Gastroenterology and Hepatology, 2018. View at Publisher · View at Google Scholar
  • Tzu-Chieh Lin, Kazuki Yoshida, Sara K. Tedeschi, Mirhelen Mendes de Abreu, Nikroo Hashemi, and Daniel H. Solomon, “Risk of Hepatitis B Virus Reactivation in Patients With Inflammatory Arthritis Receiving Disease-Modifying Antirheumatic Drugs: A Systematic Review and Meta-Analysis,” Arthritis Care & Research, 2018. View at Publisher · View at Google Scholar
  • Jiang Su, Li Long, and Kun Zou, “Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis,” Clinical Rheumatology, 2018. View at Publisher · View at Google Scholar
  • Mohsen Moghoofei, Shayan Mostafaei, Mahdi Mahmoudi, Amir Ashraf-Ganjouei, and Hoda Kavosi, “HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis,” Microbial Pathogenesis, vol. 114, pp. 436–443, 2018. View at Publisher · View at Google Scholar
  • Laura Niccoli, Emanuele Cassarà, Fabrizio Cantini, Carlotta Nannini, Corrado Blandizzi, Stefania Mantarro, Maurizio Benucci, Olga Kaloudi, Marta Mosca, Ombretta Di Munno, Delia Goletti, and Francesca Li Gobbi, “Personalization of biologic therapy in patients with rheumatoid arthritis: Less frequently accounted choice-driving variables,” Therapeutics and Clinical Risk Management, vol. 14, pp. 2097–2111, 2018. View at Publisher · View at Google Scholar
  • Stefano Piaserico, Francesco Messina, and Francesco Paolo Russo, “Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations,” American Journal of Clinical Dermatology, 2019. View at Publisher · View at Google Scholar
  • Joe Sasadeusz, Andrew Grigg, Peter D. Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G. Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G. Gish, and Kumar Visvanathan, “Screening and Prophylaxis to Prevent Hepatitis B Reactivation,” Clinics in Liver Disease, 2019. View at Publisher · View at Google Scholar
  • Chak Sing Lau, Faith Chia, Leonila Dans, Andrew Harrison, Tsu Yi Hsieh, Rahul Jain, Seung Min Jung, Mitsumasa Kishimoto, Ashok Kumar, Khai Pang Leong, Zhanguo Li, Juan Javier Lichauco, Worawit Louthrenoo, Shue Fen Luo, Rong Mu, Peter Nash, Chin Teck Ng, Bagus Suryana, Linda Kurniaty Wijaya, and Swan Sim Yeap, “2018 update of the APLAR recommendations for treatment of rheumatoid arthritis,” International Journal of Rheumatic Diseases, 2019. View at Publisher · View at Google Scholar
  • Zhuoya Zhang, Wei Deng, Qizhe Wu, and Lingyun Sun, “Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis,” Immunotherapy, 2019. View at Publisher · View at Google Scholar